Rocket Pharmaceuticals SG&A Expense (Quarterly) Insights

Rocket Pharmaceuticals Inc (RCKT)

23.47 +0.70 (+3.07%) USD | NASDAQ | May 03, 16:00

23.46 -0.01 (-0.04%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	21.54M
September 30, 2023	18.58M
June 30, 2023	17.37M
March 31, 2023	15.82M
December 31, 2022	19.04M
September 30, 2022	15.10M
June 30, 2022	12.85M
March 31, 2022	11.77M
December 31, 2021	11.32M
September 30, 2021	10.02M
June 30, 2021	9.518M
March 31, 2021	10.91M
December 31, 2020	9.145M
September 30, 2020	5.73M
June 30, 2020	6.828M
March 31, 2020	7.163M
December 31, 2019	5.697M
September 30, 2019	4.336M
June 30, 2019	4.403M
March 31, 2019	3.808M
December 31, 2018	2.865M

Date	Value
September 30, 2018	2.268M
June 30, 2018	4.10M
March 31, 2018	8.662M
December 31, 2017	9.426M
September 30, 2017	1.831M
June 30, 2017	0.702M
March 31, 2017	0.585M
December 31, 2016	2.746M
September 30, 2016	2.311M
June 30, 2016	2.315M
March 31, 2016	2.522M
December 31, 2015	2.309M
September 30, 2015	1.825M
June 30, 2015	1.728M
March 31, 2015	1.98M
December 31, 2014	0.775M
September 30, 2014	0.843M
June 30, 2014	0.332M
March 31, 2014	0.162M
December 31, 2013	0.082M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.336M

Minimum

Sep 2019

21.54M

Maximum

Dec 2023

11.43M

Average

10.91M

Median

Mar 2021

SG&A Expense (Quarterly) Benchmarks